CPhI 2009 participation has been a great success
Cerbios-Pharma SA is proud to announce the go-life of the new Company image.
The change occurs after fifteen years from the establishment of Cerbios-Pharma SA as a merger of three companies: CERNITIN SA, BIOFERMENT SA and SAPEC SA in 1994.
The name CERBIOS itself was in fact created by partially using the initials of the three original companies.
The company logo created in 1994 also took over the same colours of the corresponding companies as shown in the company logo known so far.
The names of two of the original companies were however maintained within Cerbios-Pharma SA as division names: Bioferment Division (for the biological activities) and Sapec Division (for the chemical activities).
After more than fifteen years of evolution and investments made by Cerbios’ shareholders in both, Chemistry and Biotechnology, the company image reflected in the logo, website, brochure and presentations, wasn’t representing the reality anymore with a clear understatement.
reflects a company that has radically changed during the past 10 years. All visitors including partners or potential new partners of the production site were in fact surprised to see a state-of-the-art and sophisticated plant very different from what they saw in public domain information
The new company image therefore definitely.
The logo is also directly related to our activities: the orange dots, represent “small molecules” therefore the chemical activities; the larger blue form shows a “large molecule” which corresponds to the biological activities.
With this change, also the divisions were changed in more familiar Chemical and Biological Divisions.
The website has a completely new design and aspect. It is now showing all Cerbios-Pharma SA activities, services as well as all our products.
Pages like JOBS, SITEMPAP and LINKS are complementary to technical information.
We are sure that some of our partners or past contacts will discover something new about Cerbios-Pharma SA.
Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners world-wide.
Exclusive, third-party manufacturing services are offered by the Chemical Division for HPAIs and by the Biological Division for monoclonal antibodies, recombinant proteins and pharma probiotics.
Cerbios provides full CMC support to its world-wide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.